Cambridge Investment Research Advisors’s BioNTech BNTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $451K | Sell |
4,237
-110
| -3% | -$11.7K | ﹤0.01% | 2637 |
|
|
2025
Q1 | $396K | Sell |
4,347
-14
| -0.3% | -$1.28K | ﹤0.01% | 2648 |
|
|
2024
Q4 | $497K | Sell |
4,361
-216
| -5% | -$24.6K | ﹤0.01% | 2437 |
|
|
2024
Q3 | $544K | Buy |
4,577
+154
| +3% | +$18.3K | ﹤0.01% | 2338 |
|
|
2024
Q2 | $355K | Sell |
4,423
-5
| -0.1% | -$401 | ﹤0.01% | 2571 |
|
|
2024
Q1 | $409K | Buy |
4,428
+719
| +19% | +$66.4K | ﹤0.01% | 2448 |
|
|
2023
Q4 | $391K | Sell |
3,709
-271
| -7% | -$28.6K | ﹤0.01% | 2395 |
|
|
2023
Q3 | $432K | Buy |
3,980
+148
| +4% | +$16.1K | ﹤0.01% | 2207 |
|
|
2023
Q2 | $414K | Buy |
3,832
+655
| +21% | +$70.8K | ﹤0.01% | 2269 |
|
|
2023
Q1 | $396K | Sell |
3,177
-4,727
| -60% | -$589K | ﹤0.01% | 2259 |
|
|
2022
Q4 | $1.19M | Sell |
7,904
-171
| -2% | -$25.7K | 0.01% | 1394 |
|
|
2022
Q3 | $1.09M | Sell |
8,075
-367
| -4% | -$49.5K | 0.01% | 1415 |
|
|
2022
Q2 | $1.26M | Sell |
8,442
-394
| -4% | -$58.8K | 0.01% | 1308 |
|
|
2022
Q1 | $1.51M | Buy |
8,836
+1,758
| +25% | +$300K | 0.01% | 1309 |
|
|
2021
Q4 | $1.83M | Buy |
7,078
+3,492
| +97% | +$900K | 0.01% | 1205 |
|
|
2021
Q3 | $979K | Buy |
3,586
+159
| +5% | +$43.4K | ﹤0.01% | 1542 |
|
|
2021
Q2 | $767K | Sell |
3,427
-2,652
| -44% | -$594K | ﹤0.01% | 1738 |
|
|
2021
Q1 | $664K | Buy |
6,079
+589
| +11% | +$64.3K | ﹤0.01% | 1694 |
|
|
2020
Q4 | $448K | Buy |
+5,490
| New | +$448K | ﹤0.01% | 1845 |
|